We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
Section A: Submissions for registration
The committee provided advice on one submission:
- New vaccine for provisional registration for active immunisation to prevent COVID-19 (active ingredients elasomeran and imelasomeran; brandname Spikevax Bivalent Original/Omicron; sponsor Moderna Australia Pty Ltd).
Details of the ACV advice associated with this premarket item has been or will be released within the Australian Public Assessment Report (AusPAR). To browse all AusPARs see AusPAR search.
Section B: Safety
The committee was not asked to provide advice on any safety matter.
Further information
For further information on the ACV, please visit Advisory Committee on Vaccines or contact the ACV by email ACV@health.gov.au.